O-004 Effects of nal-IRI (MM-398) ± 5-fluorouracil on quality of life (QoL) in NAPOLI-1: a phase 3 study in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine
Titel:
O-004 Effects of nal-IRI (MM-398) ± 5-fluorouracil on quality of life (QoL) in NAPOLI-1: a phase 3 study in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine
Auteur:
Hubner, R. Cubillo, A. Blanc, J.-F. Melisi, D. Von Hoff, D. Wang-Gillam, A. Chen, L.-T. Becker, C. Mamlouk, K. Belanger, B. Yang, Y. de Jong, F. Siveke, J.